Catalyst Wire Dossier Catalyst Wire Dossier

DNP-Modified Autologous Tumor Cell Vaccine

DNP-modified autologous tumor cell vaccine · AVAX Technologies
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DNP-Modified Autologous Tumor Cell Vaccine, covering 2015-12-03 to 2015-12-03. Get the full timeline:

Most recent: Clinical Trial Update: DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing